mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.4 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.4 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.4 |